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Abstract
Background: Suicide is the second leading cause of death among adolescents in the USA, and rates are rising.
Methods to identify individuals at risk are essential for implementing prevention strategies, and the development of
a biomarker can potentially improve prediction of suicidal behaviors. Prediction of our previously reported SKA2
biomarker for suicide and PTSD is substantially improved by questionnaires assessing perceived stress or anxiety
and is therefore reliant on psychological assessment. However, such stress-related states may also leave a biosignature
that could equally improve suicide prediction. In genome-wide DNA methylation data, we observed significant overlap
between waking cortisol-associated and suicide-associated DNA methylation in blood and the brain, respectively.
Results: Using a custom bioinformatic brain to blood discovery algorithm, we derived a DNA methylation biosignature
that interacts with SKA2 methylation to improve the prediction of suicidal ideation in our existing suicide prediction
model across both blood and saliva data sets. This biosignature was independently validated in the Grady Trauma
Project cohort and interacted with HPA axis metrics in the same cohort. The biosignature showed a relationship with
immune status by its correlation with myeloid-derived cell proportions in all data sets and with IL-6 measures in a
prospective postpartum depression cohort. Three probes showed significant correlations with the biosignature:
cg08469255 (DDR1), cg22029879 (ARHGEF10), and cg24437859 (SHP1), of which SHP1 methylation correlated with
immune measures.
Conclusions: We conclude that this biosignature interacts with SKA2 methylation to improve suicide prediction and
may represent a biological state of immune and HPA axis modulation that mediates suicidal behavior.
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Childhood trauma
Background
Suicide accounts for 1.4 % of worldwide deaths annually,
posing a serious public health issue [1]. Based on 2014
data, it is the second leading cause of death among ado-
lescents, and the tenth leading cause of death for all ages
in the USA [2]. Given the rising rates of suicide in the
USA, methods to identify individuals at risk for imple-
menting prevention strategies are urgently needed [3].
Recently, our laboratory identified a DNA methylation
mark that is associated with suicide in a postmortem
brain tissue cohort at a CpG (cg13989295) located within
a single nucleotide polymorphism (SNP), rs7208505, in
the spindle- and kinetochore-associated protein 2 (SKA2)
where the reference allele of rs7208505 eliminates the
CpG. The observed epigenetic association with suicide
was replicated in two additional brain tissue cohorts and
with suicidal behaviors including suicidal ideation (SI) and
attempt (SA) in peripheral blood in three living cohorts
[4]. In our original work, gene expression of SKA2 was
correlated with DNA methylation at this position and was
significantly decreased in suicide decedents. Several recent
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independent studies have observed decreased expression
of SKA2 in both the blood of violent suicide completers
[5] and in the prefrontal cortex of suicide victims [4, 6],
the latter of which was also associated with decreased
protein levels.
The SKA2 protein is thought to interact with the
hypothalamic-pituitary-adrenal (HPA) axis by chaperon-
ing the glucocorticoid receptor (GR) from the cytoplasm
to the nucleus upon cortisol binding [7]. Once in the
nucleus, the GR can interact with genomic DNA and
influence gene expression involved in negative feedback
regulation of the HPA axis response. In two independent
cohorts with high levels of childhood trauma, elevated
SKA2 DNA methylation in peripheral blood before
administration of the TRIER social stress test was signifi-
cantly associated with a blunted post-test cortisol level,
while SKA2 DNA methylation before the dexametha-
sone suppression test (DST) was significantly associated
with elevated post-test cortisol levels [8, 9]. These data
support the interpretation that SKA2 DNA methylation
state may be an important contributor to individual
stress response.
In an attempt to identify at-risk individuals, we previ-
ously generated a suicide prediction model, which de-
scribes suicidal behavior as a function of both genotype
and methylation at the single nucleotide polymorphism
(SNP) rs7208505 in SKA2 which interacts with a state
level metric of stress or trait level metric of anxiety to
confer risk [4]. Notably, some studies demonstrate that
state level stress can be influenced by trait level anxiety
[10]. Model predictive accuracies vary between ~70 and
85 % in various cohorts and are consistent with SKA2
gene expression-based prediction accuracies reported by
other groups [8, 11]. The statistical interaction with
stress is likely related to the physiological role SKA2
plays in mediating HPA axis activity. In this context, it is
hypothesized that epigenetic variation of SKA2 may rep-
resent an underlying trait vulnerability of the HPA axis
that must interact with a state of stress to elicit risk. In
our previous work, we have identified significant interac-
tions of SKA2 with various self-reported psychological
scales to influence suicide risk. The scales vary by study
cohort and include the Child Trauma Questionnaire
(CTQ), the Perceived Stress Scale, waking salivary cor-
tisol levels, and various metrics of anxiety including
self-reported binary estimates and those quantified by
the Self-Report for Childhood Anxiety Related Disor-
ders (SCARED) [4, 8, 9]. Furthermore, our work and
others have noted an increased model efficacy in sub-
groups of individuals having experienced childhood
trauma [8, 9, 12, 13]. It is possible that high values in
the stress metrics represent a biological state that may
be related to HPA axis function. Despite the possibility
to assess these states using questionnaires, the use of
self-reported scales has many drawbacks including a
lack of standardization across studies, variability in psycho-
metric properties, and variability in the subjective rating of
stress levels. In the clinical context, the administration of
questionnaires requires time and patient compliance.
Recent attempts have been made to circumvent the
use of psychological assessments and develop biomarker
proxies [11, 14]. A challenge for the identification of
peripheral tissue-based epigenetic biomarkers in the
context of psychiatry is the generalizability of the identi-
fied peripheral epigenetic variation in the brain. We have
hypothesized previously that circulating steroid hor-
mones such as cortisol may mark peripheral tissue DNA
on the epigenetic level while affecting behavior through
central nervous system (CNS) specific actions [15–17].
In support of this hypothesis, the initial objective of this
study was to evaluate if cortisol-associated DNA methy-
lation levels in peripheral tissues (blood and saliva) are
enriched among suicide-associated DNA methylation
levels in the brain.
While systemic factors like cortisol may influence epi-
genetic patterns across-tissues and may represent rele-
vant biomarkers interacting with SKA2, we did not wish
to limit our analysis to cortisol-associated probes alone.
Thus, the second major objective of this study was to
generate an epigenetic biosignature of SKA2-interacting
state markers in a bioinformatically driven and unbiased
manner and to understand the underlying biological
context driving any identified biosignatures.
Results
Overrepresentation of peripheral cortisol-associated loci
among brain-associated suicide genes
To address our first objective, we attempted to address
the degree to which peripheral blood- or saliva-based
DNA methylation profiles are indicative of epigenetic
profiles in the brain related to suicidal behaviors. One po-
tential substrate for peripheral tissue-brain overlap is a
cross-tissue reprogramming by the systemic influence of
hormones. For Genetics of Recurrent Early-Onset Depres-
sion (GenRED) Offspring, we identified 20,146 and 22,865
probes that were nominally associated with the area under
the curve (AUC) of waking weekday cortisol in blood and
saliva samples, respectively (Additional files 1 and 2).
To increase statistical power, we performed a combined
analysis of blood and saliva samples using a linear
model with age, sex, tissue type (blood or saliva), and
cell type proportion as covariates and identified 22,425
loci associated with the AUC of waking weekday corti-
sol (Additional file 3). A pathway enrichment analysis
of the genes significantly associated (P < 0.001) with the
AUC of weekday waking cortisol in GenRED Offspring
blood and saliva using the tool g:Profiler revealed an
enrichment of neural development pathways at varying
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levels of significance (Table 1) [18, 19]. Given the import-
ance of dysregulated cortisol biology to suicidal behaviors,
cortisol-associated methylation probes in peripheral blood
(N = 18) and saliva (N = 20) from the GenRED Offspring
cohorts were assessed for an overrepresentation with
those probes significantly associated with completed
suicide separately in postmortem prefrontal cortical
neurons and non-neurons (N = 45). Cortisol-associated
probes within genes or gene regulatory sites were
significantly overrepresented among prefrontal neuron
suicide-associated genes and genes previously identified
as associated with cortisol stress reactivity (Table 2)
[20]. These findings indicate that there may be common
pathways between cortisol biology and suicidal behavior
and that the epigenetic marks of suicide-associated hor-
monal changes may be detectable in peripheral tissues.
Algorithmic identification of SKA2-interacting biosignature
for DNA methylation-based suicidal behavior prediction
In light of the above findings, our strategy to approach
our second objective of generating a biosignature of
SKA2-interacting state markers was to identify epigen-
etic variation interacting with SKA2 that was consistent
across brain and peripheral tissues. The full algorithm is
explained in Additional file 4: Figure S1. Briefly, DNA
methylation in prefrontal cortex neurons at each probe
was assessed for statistical interaction with rs7208505
CpG methylation (chr17:59110368, hg38) in a linear
model controlling for age, sex, and rs7208505 genotype
and identified 669 probes below a P value cutoff of 0.005
(Fig. 1a, Additional file 4: Result S1). Of these 669
probes, 72 exhibited an AUC prediction for SA in the
top 25th percentile (AUC > 0.825) in the GenRED Off-
spring blood cohort (Fig. 1b; Table 3). The methylation
at these 72 probes was used to train a principal compo-
nent analysis (PCA) model on the GenRED Offspring
blood data, which was then used to predict PCA models
in the other data sets. The first eigenvector was used to
assess suicidal behavior prediction in the original predic-
tion model, replacing the stress measure with the PCA
first eigenvector. All steps were evaluated by the Monte
Carlo method and found to be statistically significant
(P < 0.001, Additional file 4: Result S1). This approach
predicted SI in PPD cohort blood with an AUC of
0.88 (95 % CI 0.75–1; P = 0.041) and in GenRED Off-
spring saliva with an AUC of 0.81 (95 % CI 0.59–1;
P = 0.011) (Fig. 1c; Table 4). These high-prediction
AUCs provide evidence that the PCA first eigenvector
may represent a methylation SKA2 “interaction bio-
signature” that is predictive of suicidal behavior in the
existing suicide prediction model and replaces the need
for a stress questionnaire.
Table 1 Gene ontology results
Rank Probability estimate Expected probability P value Term ID Term name
1 0.211 0.053 1.74 × 10−5 GO:0007399 Nervous system development
2 0.15 0.059 3.63 × 10−5 GO:0030182 Neuron differentiation
3 0.156 0.057 6.40 × 10−5 GO:0048699 Generation of neurons
4 0.161 0.056 8.19 × 10−5 GO:0022008 Neurogenesis
5 0.128 0.061 1.42 × 10−4 GO:0048666 Neuron development
6 0.809 0.036 2.94 × 10−4 GO:0044424 Intracellular part
7 0.111 0.063 3.77 × 10−4 GO:0000904 Cell morphogenesis involved in differentiation
8 0.093 0.066 9.76 × 10−4 GO:0048667 Cell morphogenesis involved in neuron differentiation
9 0.224 0.048 1.08 × 10−3 GO:0009653 Anatomical structure morphogenesis
10 0.085 0.067 2.16 × 10−3 GO:0007409 Axonogenesis
11 0.184 0.05 3.32 × 10−3 GO:0048468 Cell development
12 0.093 0.064 3.37 × 10−3 GO:0048812 Neuron projection morphogenesis
13 0.271 0.045 3.62 × 10−3 GO:0065008 Regulation of biological quality
14 0.817 0.035 5.78 × 10−3 GO:0005622 Intracellular
15 0.271 0.045 6.13 × 10−3 GO:0009893 Positive regulation of metabolic process
16 0.085 0.065 6.92 × 10−3 GO:0061564 Axon development
17 0.362 0.041 0.0105 GO:0048856 Anatomical structure development
18 0.709 0.036 0.0107 GO:0043229 Intracellular organelle
19 0.108 0.058 0.0112 GO:0031175 Neuron projection development
20 0.279 0.044 0.0161 GO:0030154 Cell differentiation
Gene ontology analysis of genes significantly associated with weekday AUC cortisol measured in GenRED Offspring blood and saliva samples using the
tool g:Profiler
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Independent validation of SKA2 model interaction
biosignature performance
The interaction biosignature model was validated using
methylation array data from the Grady Trauma Project
(GTP), a sample of urban minorities with low socioeco-
nomic status and high rates of traumatic experience and
PTSD. On the entire sample, the prediction model
generated an AUC of 0.50 (95 % CI 0.42–0.58; P = 0.724)
for prediction of SI in all 376 individuals. Based on
recent publications that have provided evidence that
both PTSD and substance abuse may confound SKA2
methylation [9, 21], we selected a subset of the GTP
sample with no history of PTSD or drug use (N = 115; 6
cases, 109 controls), where a combination of SKA2 and
the interaction biosignature predicted SI with an AUC of
0.73 (95 % CI 0.59–0.87; P = 0.050) (Fig. 1d; Table 4)
[12]. Although our interaction biosignature model was
unsuccessful in suicidal behavior prediction across the
entire GTP cohort, prediction was successful in a
subset without PTSD. This altered suicidal behavior
prediction with PTSD is consistent with previously
published findings [9].
Association of interaction biosignature metrics with HPA
axis function
To improve our understanding of the biological rele-
vance of the interaction biosignature, we assessed bio-
signature loci for a relationship with various metrics of
HPA axis function in two cohorts with high levels of
childhood trauma as assessed by the CTQ. The inter-
action biosignature eigenvector interacted with CTQ
scores to associate with post-test AUC cortisol levels
following the administration of the TRIER social stress
test (biosignature β = 3446.9 ± 1631.2, P = 0.038; CTQ
β = −40.6 ± 12.9, P = 0.002; interaction β = −92.8 ± 45.0,
P = 0.043, F = 4.5, df = 4/81, model P = 0.038) (Additional
file 4: Figure S2A). In the GTP sample subset, the
interaction biosignature eigenvector interacted with CTQ
scores to associate with the natural log of the day 2
cortisol following administration of the DST (biosignature
β = −6.4 ± 2.8, P = 0.027; CTQ β = 0.096 ± 0.037, P = 0.012;
interaction β = 0.22 ± 0.095, P = 0.027, F = 2.4, df = 4/49,
model P = 0.027) (Additional file 4: Figure S2B). Taken to-
gether, the data suggest that SKA2 interaction biosignature
values associate with early life trauma status to influence
HPA axis sensitivity.
Assessment of biological relevance of SKA2 model
interaction biosignature
We reasoned that the biological underpinnings of our
SKA2 interaction biosignature may be related to variation
in peripheral immune cells, as inflammation may be influ-
enced by state factors like stress. The predicted proportion
of granulocyte and monocyte content (myeloid-derived
cells) showed a negative association with the interaction
biosignature across all data sets (Fig. 2a–d), with significant
correlations in GenRED Offspring blood (rho = −0.76,
P = 2.7 × 10−4), PPD cohort blood (rho = −0.29, P = 0.034),
and GTP blood (rho = −0.57, P = 2.4 × 10−7) and a
non-significant association in GenRED Offspring sal-
iva (rho = −0.39, P = 0.092). Substituting the propor-
tion of myeloid-derived cells for the interaction
Table 2 Overrepresentation analysis
Cohort Comparison Significance level Expected probability Probability estimate Binomial test P value
GenRED Offspring
Saliva, cortisol
Neuron, suicide 0.05 0.507 0.614 3.47 × 10−102
0.01 0.158 0.242 8.70 × 10−28
0.001 0.019 0.026 0.332
GenRED Offspring
Blood, cortisol
Neuron, suicide 0.05 0.470 0.569 2.97 × 10−86
0.01 0.132 0.209 1.30 × 10−26
0.001 0.015 0.039 9.71 × 10−3
Combined GenRED Offspring
Blood and saliva, cortisol
Neuron, suicide 0.05 0.522 0.618 1.68 × 10−81
0.01 0.187 0.251 1.34 × 10−15
0.001 0.032 0.035 0.851
Houtepen et al. [20]
Cortisol
Neuron, suicide 0.05 0.470 0.578 2.01 × 10−105
0.01 0.119 0.193 6.02 × 10−32
0.001 0.011 0.029 3.15 × 10−3
Combined GenRED Offspring
Blood and saliva, cortisol
Houtepen et al. [20]
Cortisol
0.05 0.522 0.603 6.70 × 10−60
0.01 0.187 0.264 1.08 × 10−25
0.001 0.032 0.061 4.96 × 10−3
Overrepresentation analysis of genes significantly associated with AUC weekday cortisol measures in GenRED Offspring blood and saliva samples, genes
significantly associated with suicide in postmortem prefrontal cortex neurons, and genes associated with AUC cortisol in blood from Houtepen et al. [20]
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biosignature in the prediction model yielded compar-
able predictions of SI (Additional file 4: Figure S3;
Table 4) in GenRED Offspring saliva (AUC = 0.79;
95 % CI 0.56–1; P = 0.28), PPD cohort blood, (AUC =
0.83; 95 % CI 0.61–1; P = 0.003), and GTP subset
(AUC = 0.73; 95 % CI 0.55–0.9; P = 0.99). The PPD
cohort (trimester >1) showed a non-significant correl-
ation between peripheral blood interleukin-6 (IL-6)
levels and the predicted myeloid-derived cell proportion
(Fig. 3a; rho = −0.32, P = 0.054); however, there was no
correlation between IL-6 and the interaction biosignature
(rho = 0.05, P = 0.80). Increased granulocyte and monocyte
counts along with altered IL-6 levels may indicate increased
inflammation and imply that our interaction biosignature
could be an indicator of an immune state involved in sui-
cide etiology [22]. The PPD cohort also showed a signifi-
cant correlation between perceived stress and the
interaction biosignature (Fig. 3b; rho = 0.33, P = 0.019),
suggesting that the interaction biosignature may represent
a biological state of both stress and inflammation.
Identification of probes driving the SKA2 model
interaction biosignature
Each of the 72 probes comprising the interaction bio-
signature was tested for correlation to the first eigen-
vector of the PCA model across each data set to
identify subsets of probes that may be driving a
majority of the variation. Three probes exhibited sig-
nificant correlations (P < 0.05) consistent across all co-
horts (Additional file 4: Table S3): cg08469255 (DDR1),
cg22029879 (ARHGEF10), and cg24437859 (SHP1).
Microarray-derived DNA methylation values were vali-
dated by pyrosequencing in select loci (Additional file 4:
Figure S4). Methylation at cg24437859 used in place of
the interaction biosignature predicted SI in GenRED
Offspring saliva with an AUC of 0.77 (95 % CI 0.54–1;
P = 0.20) and in PPD cohort blood with an AUC of 0.84
(95 % CI 0.63–1; P = 0.001). Probe cg24437859 is lo-
cated within the promoter of SHP1, which has known
immune system functions, providing a plausible bio-
logical explanation for the statistical interaction with
Fig. 1 Discovery of interaction biosignature probes and prediction of suicidal ideation using interaction biosignature in multiple cohorts. a Volcano
plot in prefrontal cortex neurons (cases, N = 22; controls, N = 23) of the interaction of individual probe methylation with rs7208505 methylation and
genotype. b Probes with an interaction P value <0.005 (N = 669) were optimized for prediction of SA in GenRED Offspring blood. Probes with an AUC
prediction above 0.825 (N = 72) were used to train a PCA model. c ROC curves of prediction of SI in GenRED Offspring saliva and PPD cohort blood
using the first eigenvectors of predicted PCAs. d ROC curves of prediction of SI in the whole GTP cohort and a subset of drug-naïve, non-PTSD
individuals (cases = 6; controls = 109)
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Table 3 Probes from interaction biosignature contributing to the PCA model
Probe ID Location (hg19) Gene symbol Gene name
cg01060471 chr10:103911733 NOLC1 Nucleolar and coiled body phosphoprotein 1
cg01252219 chr12:110302105 GLTP Glycolipid transfer protein
cg02068690 chr2:25600451 DTNB Dystrobrevin, beta
cg02097235 chr16:1116799 SSTR5-AS1 SSTR5 antisense RNA 1
cg02246725 chr11:2014127 HOTS H19 opposite tumor suppressor
cg02340818 chr8:145808436 ARHGAP39 Rho GTPase activating protein 39
cg02464608 chr3:122631723 SEMA5B Semaphorin 5B
cg02516957 chr8:128011063
cg02953125 chr2:1079100 SNTG2 Syntrophin, gamma 2
cg03198117 chrX:152939967 PNCK Pregnancy up-regulated nonubiquitous CaM kinase
cg03351894 chrX:48686200 ERAS ES cell expressed Ras
cg03782771 chr4:152801238
cg03887528 chr2:231090531 SP140 SP140 nuclear body protein
cg06363485 chr6:41207376 TREML4 Triggering receptor expressed on myeloid cells like 4
cg06774087 chr5:79647614 CRSP8P Mediator complex subunit 27 pseudogene
cg07483709 chr10:29439573
cg07589300 chr4:1404128
cg07787977 chr1:962651 AGRN Agrin
cg08119631 chrX:118822815 SEPT6 Septin 6
cg08469255 chr6:30851069 DDR1 Discoidin domain receptor tyrosine kinase 1
cg08674415 chr16:34430905
cg08720806 chr11:125142671 PKNOX2 PBX/knotted 1 homeobox 2
cg08795752 chr9:136293271 ADAMTS13 ADAM metallopeptidase with thrombospondin type 1 motif, 13
cg09105334 chr17:15683060
cg11450546 chr19:43965012 LYPD3 LY6/PLAUR domain containing 3
cg11496113 chr5:34627766
cg11780096 chr2:178976254 RBM45 RNA binding motif protein 45
cg11880367 chr10:80141181 LINC00856
cg12378817 chr10:133961235 JAKMIP3 Janus kinase and microtubule interacting protein 3
cg12622680 chr7:158819620 LINC00689
cg12833118 chr4:2572546
cg12967319 chr14:101291997 MEG3 Maternally expressed 3 (non-protein coding)
cg13466253 chr20:3731334 HSPA12B Heat shock 70kD protein 12B
cg13798679 chr1:36617570 TRAPPC3 Trafficking protein particle complex 3
cg14439102 chr9:80360719 GNAQ Guanine nucleotide binding protein (G protein), q polypeptide
cg14509196 chr15:25494565 SNORD115-44 Small nucleolar RNA, C/D box 115-44
cg15071166 chr17:3771325 CAMKK1 Calcium/calmodulin-dependent protein kinase kinase 1, alpha
cg15302379 chr10:102821848 KAZALD1 Kazal-type serine peptidase inhibitor domain 1
cg15508401 chr2:239997380 HDAC4 Histone deacetylase 4
cg15677087 chr20:61584850 SLC17A9 Solute carrier family 17, member 9
cg15838142 chr17:77184010 RBFOX3 RNA binding protein, fox-1 homolog 3
cg16900102 chr7:98283412
cg16943635 chr11:62067691 SCGB1D4 Secretoglobin, family 1D, member 4
cg17267737 chr7:158819531 LINC00689
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Table 3 Probes from interaction biosignature contributing to the PCA model (Continued)
cg17813840 chr15:79852956
cg18144654 chr3:127995346 EEFSEC Eukaryotic elongation factor, selenocysteine-tRNA-specific
cg18546110 chr4:10763497
cg19688321 chrX:70476177 BCYRN1 Brain cytoplasmic RNA 1
cg20704602 chr6:29635371 MOG Myelin oligodendrocyte glycoprotein
cg20929545 chr11:118958046 HMBS Hydroxymethylbilane synthase
cg21066636 chr17:4675292 TM4SF5 Transmembrane 4 L six family member 5
cg21352158 chr8:832917 ERICH1-AS1 ERICH1 antisense RNA 1
cg21407196 chr1:46751975 LRRC41 Leucine rich repeat containing 41
cg21729235 chrX:100739272 ARMCX4 Armadillo repeat containing, X-linked 4
cg22029879 chr8:1790861 ARHGEF10 Rho guanine nucleotide exchange factor 10
cg22133973 chr6:170789640 PSMB1 Proteasome subunit beta 1
cg22184136 chr6:30038720 RNF39 Ring finger protein 39
cg22939113 chr19:40719949 MAP3K10 Mitogen-activated protein kinase kinase kinase 10
cg22954621 chr10:13514626 BEND7 BEN domain containing 7
cg23043139 chr3:13678918 FBLN2 Fibulin 2
cg23374863 chr14:94984140 SERPINA12 Serpin family A member 12
cg24112628 chr6:150174215 LRP11 Low-density lipoprotein receptor-related protein 11
cg24416190 chr4:186007379
cg24437859 chr12:7066614 PTPN6 Protein tyrosine phosphatase, non-receptor type 6
cg25132241 chr14:92396859 FBLN5 Fibulin 5
cg25133951 chr1:178575267
cg25215117 chr17:11461665 SHISA6 Shisa family member 6
cg25447359 chr22:30790057
cg25477843 chr8:145061318 PARP10 Poly (ADP-ribose) polymerase family, member 10
cg26224354 chr7:1096374 GPR146 G protein-coupled receptor 146
cg26305504 chr19:947612 ARID3A AT-rich interactive domain 3A
cg26493346 chr16:1812273 MAPK8IP3 Mitogen-activated protein kinase 8 interacting protein 3
Table 4 Prediction model results
Cohort N Outcome Cases Controls Interaction AUC 95 % CI P value
GenRED Offspring blood 18 Attempt 4 14 Biosignature 0.768 0.47–1 0.052
GenRED Offspring saliva 20 Ideation 5 15 Biosignature 0.807 0.59–1 0.011
PPD cohort blood 51 Ideation 8 43 Biosignature 0.884 0.75–1 0.041
GTP blood 376 Ideation 63 313 Biosignature 0.500 0.42–0.58 0.724
GTP subset blood 115 Ideation 6 109 Biosignature 0.727 0.59–0.87 0.050
GenRED Offspring blood 18 Attempt 4 14 % myeloid 0.732 0.40–1 0.28
GenRED Offspring saliva 20 Ideation 5 15 % myeloid 0.788 0.56–1 0.28
PPD cohort blood 51 Ideation 8 43 % myeloid 0.834 0.61–1 0.003
GTP subset blood 115 Ideation 6 109 % myeloid 0.728 0.55–0.9 0.99
Prediction model results for all cohorts using either the interaction biosignature or the myeloid-derived proportion as the interaction term. P values are derived
from Monte Carlo permutation
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SKA2 identified in our data. This relationship was investi-
gated further in the PPD cohort, where plasma cytokine
levels were available. CpG methylation at cg24437859 cor-
related with IL-6 levels (rho = −0.37, P = 0.035; Fig. 3c)
and the predicted myeloid-derived cell proportions
(rho = 0.74, P = 1.4 × 10−8; Fig. 3d) in PPD cohort blood
collected during the second or third trimester.
Discussion
In this study, we used brain, saliva, and whole-blood
DNA methylation data of several cohorts to derive a bio-
signature of a stress state that may aid in the prediction
of suicide. Using a statistically oriented approach that
analyzed cross-tissue epigenetic reprogramming by cor-
tisol and interaction with the previous reported SKA2
suicide biomarker, we generated an epigenetic biosigna-
ture. To assess the effects of cortisol on DNA methyla-
tion patterns, we performed a pathway enrichment
analysis of genes with methylation significantly associ-
ated with AUC weekday cortisol in the GenRED Off-
spring samples, which revealed an enrichment of neural
developmental pathways. This data is consistent with the
notion that there are a number of genes that regulate
both cortisol and neural development. Early life stress,
for example, is known to affect both brain development
and HPA axis function later in life. Several recent studies
in mice reported impaired neurogenesis and cognition
with early life stress [23], as well as altered CpG methy-
lation in NR3C1, the gene encoding the glucocorticoid
receptor [24]. Similar adverse effects have been observed
in humans with exposure to early life stress [25, 26].
This link was further bolstered by an overrepresentation
analysis that showed an enrichment of AUC weekday
cortisol-associated genes in GenRED Offspring blood
and saliva with suicide-associated genes in prefrontal
neurons as well as previously identified genes associated
with cortisol stress reactivity in blood [20], indicating
that there are consistent cross-tissue DNA methylation
changes with cortisol dysregulation and a behavioral out-
come such as suicide. Our results are consistent with a
model whereby suicide-associated HPA axis dysregula-
tion causes an overproduction of circulating cortisol,
which causes DNA methylation changes in various tis-
sues, resulting in behavioral changes through the actions
Fig. 2 Myeloid-derived cell proportions correlated with the interaction biosignature in all cohorts and were predictive of suicidal behavior. Correlations
were observed between the interaction biosignature and the proportion of myeloid-derived cells in a GenRED Offspring blood (P = 2.7 × 10−4), b saliva
(P = 0.092), c PPD cohort blood (P = 0.034), and d GTP blood (P = 2.4 × 10−7)
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of DNA methylation in the brain, while leaving measur-
able marks in the periphery that enable the biomarker-
based prediction of suicidal ideation and behaviors.
We present a biosignature that is representative of
probes with a significant interaction with both SKA2
genotype and methylation in prefrontal neurons and is
predictive of suicidal ideation in three cohorts. Using
this biosignature in interaction with SKA2 can replace
the stress questionnaire metrics used as interactive co-
variates in our original suicide prediction model. We
used Monte Carlo-based testing for significance by gen-
erating a similar PCA eigenvector from randomly se-
lected sets of 72 probes. Randomly selected probes
yielded predictions inferior to that of the biosignature in
almost all bootstraps, suggesting that improved model
prediction accuracy is not due to the underlying data
structure. The biosignature performance did not reach
significance by this method in saliva, possibly due to the
confounding influence of buccal-derived cell types influ-
encing the variation generated at biosignature loci. This
interaction biosignature showed correlation with percent
granulocyte and monocyte (both myeloid lineage-derived
cells) content in all peripheral tissue data sets, suggest-
ing a possible immune modulation associated with the
methylation at these 72 probes. Both the interaction bio-
signature and myeloid-derived cell levels also correlated
with serum interleukin-6 (IL-6) in the PPD cohort, fur-
ther suggesting that a pro-inflammatory immune modu-
lation is interacting with SKA2 methylation to mediate
suicidal behavior. Consistent with our findings, increased
pro-inflammatory cytokines, including IL-6, have been
observed in the CSF of suicide attempters [27] and in
the prefrontal cortex of teenage suicide victims [28, 29].
Additionally, PTSD is known to show increased levels of
C-reactive protein and IL-6, which are both signs of in-
creased inflammation [30–35]. Biological changes, such
as inflammation and immune system modulation, are
known to be associated with suicide and related mood
disorders. For example, lymphocytes are known to play a
role in HPA axis dysfunction and have been used to
assess many different psychiatric disorders, including de-
pression and suicide [36, 37]. Suicidal behavior is known
to be associated with an inflammatory state which, if
measured, may improve the prediction of such behavior.
Fig. 3 Interaction biosignature and methylation at SHP1 (cg24437859) correlated with inflammatory markers and stress measures in the
PPD cohort (trimester >1). a Levels of IL-6, an inflammatory marker, correlated with myeloid-derived cell proportion (P = 0.054). b The
interaction biosignature correlated with the perceived stress metric (P = 0.019). SHP1 methylation correlated with both c IL-6 levels (P = 0.035) and
d myeloid-derived cell proportion (P = 1.4 × 10−8)
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Substituting the percentage of myeloid-derived cells for
the interaction biosignature in the prediction model was
successful in predicting suicidal ideation in all of the co-
horts, suggesting that this interaction biosignature may be
indicative of a biological state that interacts with the trait
of SKA2 genotype and methylation to influence behavior.
In further efforts to reduce these 72 probes to a smaller
number that would help us better understand the biology
and facilitate practical implementation, we assessed the
genes displaying epigenetic variation most closely mimick-
ing the PCA first eigenvector. We discovered that there
were three probes within the 72-probe interaction bio-
signature with significant correlations to the interaction
biosignature in all cohorts: cg22029879, cg08469255, and
cg24437859. ARHGEF10 (rho guanine nucleotide ex-
change factor 10; cg22029879) was identified as one of the
21 genes located on chromosome 8p, a region that is
thought to contribute to neuropsychiatric disorders, in-
cluding depression [38]. Although little evidence exists
tying ARHGEF10 to suicide etiology, this locus may be
worthy of further investigation due to its consistent asso-
ciation with the interaction biosignature across all data
sets. DDR1 (discoidin domain receptor tyrosine kinase 1;
cg08469255) is primarily involved in cell adhesion and
extracellular matrix remodeling but also has known roles
in immune and inflammatory pathways. DDR1 was shown
in a cell culture model to induce the expression of cyclo-
oxygenase (COX2), which is involved in the synthesis of
prostaglandins and has a known role in inflammation [39].
COX2 also activates the NF-κB pathway, which is involved
in inflammatory pathways and cytokine production [39]
and has been shown as a downstream target of DDR1 to
cause infiltrating macrophages to produce chemokines.
Additionally, DDR1 was also shown in a mouse model of
kidney obstruction to mediate the development of inflam-
mation and fibrosis following kidney injury [40]. Given
this evidence, DDR1 methylation could account for the
correlation of myeloid-derived cell content with the inter-
action biosignature and could also represent a target for
further investigation.
SHP1 (protein tyrosine phosphatase, non-receptor type
6; cg24437859) has been implicated in modulating neutro-
phil recruitment to inflamed tissues through modulation
of the phosphoinositol pathway [41, 42] and has been
shown to play an inhibitory role in cytokine-induced acti-
vation of the HPA axis through the JAK-STAT pathway
[43]. Furthermore, SHP1 methylation correlated with IL-6
in the PPD cohort as well as the myeloid-derived cell pro-
portion in all cohorts, altogether demonstrating biological
evidence for the statistical interaction with HPA axis rele-
vant SKA2 identified in our data. Critically, IL-6 contrib-
utes to hematopoietic stem cell fate decisions and helps to
differentiate myeloid from non-myeloid cells [42, 44]. As
such, the possibility remains that epigenetic variation in
genes like SHP1 may be important not only for differenti-
ation of hematopoietic stem cells into myeloid cells but for
regulation of pro-inflammatory cytokines and may moder-
ate the influence of pro-inflammatory cytokines on HPA
axis activity. This supposition is supported by data demon-
strating that SKA2 interaction biosignature data interacted
with CTQ scores to predict HPA axis responsivity in two
stress challenges from multiple data sets. The relationship
between the interaction biosignature signals and HPA axis
sensitivity is very similar to previously reported findings
related to the influence of SKA2 DNA methylation on
HPA axis activity from the same cohorts [8, 9].
In our independent validation in the GTP cohort (N =
376), we observed that our interaction biosignature
model was only able to predict suicidal ideation in a
smaller subset of drug-naïve individuals without a PTSD
diagnosis (N = 115) but was unsuccessful predicting in
the full GTP sample. Several recent papers on the use-
fulness of SKA2 in predicting PTSD have observed a
confounding effect of marijuana use on SKA2 methyla-
tion, which potentially inhibits the accurate prediction of
suicidal behaviors [8, 9]. Kaminsky et al. observed a sig-
nificant interaction between substance abuse and SKA2
methylation in predicting suicidal behavior in several co-
horts, and Boks et al. observed altered SKA2 methylation
with smoking, alcohol consumption, and use of medica-
tions [8, 9]. Based on these findings, it is reasonable to
assume that without taking into account substance abuse,
using SKA2 methylation to predict suicidal behaviors
could produce inaccurate results. Along with substance
abuse, trauma exposure has recently been shown to
influence SKA2 methylation [8, 9, 12]. Boks et al.
showed that development of PTSD symptoms was asso-
ciated with longitudinal decreases in SKA2 methylation
after military deployment, which is the opposite of the
positive association between SKA2 methylation and
suicide risk [4, 8]. Furthermore, Sadeh et al. observed a
positive association between genotype-adjusted SKA2
methylation and PTSD symptom severity in one military
cohort, while this PTSD association was not replicated in
a second military cohort [13], adding to the complexity
that is the interaction between SKA2 methylation, PTSD,
and suicidal behavior [12]. One biological explanation for
this interaction is altered HPA axis function in PTSD, as
shown by increased clearance of dexamethasone in the
DST [45]. Kaminsky et al. recently observed decreased day
2 cortisol in the DST in subjects diagnosed with PTSD
but not suicidal behavior, indicating increased HPA axis
sensitivity [9]. In another study, van Zuiden et al. observed
a longitudinal increase in sensitivity to dexamethasone in
T cells collected from a Dutch military cohort pre- and
post-deployment [46]. Another biological explanation for
the SKA2 methylation-PTSD relationship is that PTSD is
associated with increased inflammation, which has been
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observed in many studies showing increased levels of
C-reactive protein and IL-6 in the blood of both mili-
tary and non-military cohorts [30–35]. The relationship
between SKA2 methylation and PTSD should be studied
further to better understand the impact on suicidal
behaviors.
This study has many limitations. Sodium bisulfite
modification cannot distinguish between 5-methyl cyto-
sine (5-MC) and 5-hydroxy methyl cytosine (5-HMC)
levels. Like 5-MC, 5-HMC can vary in the brain in re-
sponse to stress [47, 48] and has been identified in vari-
ous psychiatric disorders [49, 50]. Brain tissue analyses
have the potential to be confounded by postmortem
factors such as the method and timing of tissue preser-
vation. Psychiatric diseases can often be co-morbid with
other illnesses such as cancer and heart disease, among
others [51, 52]. Despite the implication that inflamma-
tory factors may be interacting with SKA2, we did not
assess for the health status of the study subjects and any
potential impact this might have on our results. This
study is limited by using small samples that are not
representative of the general population and are biased
towards controls due to a low ratio of cases to controls
and only validated findings in a single independent sam-
ple in which suicidal behavior is only predicted in small
subsets. Ideally, these findings would be further validated
in a large sample that is more representative of the gen-
eral population to prove its usefulness in prediction of
suicidal behavior.
Conclusions
We present a biosignature that predicts suicide consist-
ently across multiple, highly variable data sets, specific-
ally youth at high risk for depression, pregnant women
at high risk for PPD, and middle-aged urban population
with high incidence of trauma and PTSD. This biosigna-
ture is cross-tissue in that it predicts suicidal behavior in
both blood and saliva samples and is based on probes
that are associated with suicide in prefrontal neurons.
To our knowledge, this is the first prediction model to
date that works in both blood and saliva and the first
suicide prediction model to use only DNA methylation
to predict suicidal behavior. Additionally, correlations of
the interaction biosignature with myeloid proportion
and stress metrics may indicate a fuller integration of
suicide etiology into the existing SKA2 suicide prediction
model. Finally, this biosignature allows us to predict
suicidal behavior without using a stress questionnaire or
assessment. Although the biosignature produces lower
prediction AUCs than the stress questionnaires, it repre-
sents a single measure that allows us to predict suicidal
behavior across all data sets, providing consistency and
better allowing for comparison across populations.
Ultimately, this work will add to the development of
early diagnostics tests that may aid in the early identifi-
cation and prevention of suicide.
Methods
Human samples
Peripheral blood and saliva samples were obtained from
separate individuals in the GenRED Offspring cohort
from Johns Hopkins [4, 53–56]. Postmortem prefrontal
cortex neurons (cases, N = 22; controls, N = 23) were ob-
tained as previously described [4], data available at NCBI
Gene Expression Omnibus (GEO) accession GSE41826.
Peripheral blood samples (cases, N = 8; controls, N = 43)
were obtained from consenting individuals in a Johns
Hopkins prospective cohort of pregnant women (PPD
cohort), as previously described [57], data available
from GEO accession GSE44132. Data from individuals
in the Grady Trauma Project (cases, N = 63; controls,
N = 313) were downloaded from the NCBI GEO ac-
cession GSE72680 [53–56]. Data on TRIER social
stress test cohort (N = 85) was downloaded from GEO
accession GSE77445 [20]. All cohorts used in model
generation and validation are described in detail in
Additional file 4: Table S1.
DNA methylation analysis
Study data was derived from genome-wide DNA methy-
lation data using the Infinium HumanMethylation450
BeadChip Array (Illumina Inc., San Diego, CA). DNA
methylation profiles for GenRED Offspring cohort
blood (cases, N = 4; controls, N = 14) and saliva (cases,
N = 5; controls, N = 15), respectively, were generated as
described below.
Infinium chip assay
Bisulfite-converted DNA was analyzed using Illumina’s
Infinium HM450 BeadChip Kit (WG-314-1001) by follow-
ing the manufacturer’s protocol. The BeadChip contains
485,577 CpG loci in human genome. Briefly, 4 μl of
bisulfite-converted DNA was added to a 0.8-ml 96-well
storage plate (Thermo Scientific), denatured in 0.014 N
sodium hydroxide, neutralized, and amplified with kit-
provided reagents and buffer at 37 °C for 20–24 h. Samples
were fragmented using kit-provided reagents and buffer at
37 °C for 1 h and precipitated by adding 2-propanol. Re--
suspended samples were denatured in a 96-well plate heat
block at 95 °C for 20 min. Twelve microliters of each sam-
ple was loaded onto a 12-sample chip, and the chips were
assembled into a hybridization chamber as instructed in
the manual. After incubation at 48 °C for 16–20 h, the
chips were briefly washed and then assembled and placed
in a fluid flow-through station for primer-extension and
staining procedures. Polymer-coated chips were image
processed in the Illumina’s iScan scanner.
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Data acquisition
Data were extracted using Methylation Module of Geno-
meStudio v1.0 Software and processed using the “minfi”
and “wateRmelon” packages in R [58, 59]. Raw data was
trimmed of probes failing quality assessment, followed
by scale-based data correction for Illumina type I relative
to type II probes. Methylated and un-methylated inten-
sity values were then quantile normalized separately
prior to the calculation of the β (beta) value based on
the following definition:
β value = (signal intensity of methylation-detection
probe)/(signal intensity of methylation − detection
probe + signal intensity of non-methylation-detection
probe + 100).
Sodium bisulfite pyrosequencing
Microarray data was validated at select probes in the
GenRED Offspring saliva cohort to corroborate array
data (Additional file 4: Figure S4). Bisulfite conversion
was carried out using EZ DNA Methylation-Gold Kit
(Zymo Research, Irvine, CA) according to the manufac-
turer’s instructions on N = 51 subjects from the Johns
Hopkins Prospective cohort. Nested PCR amplifications
were performed with a standard PCR protocol in 25 μl
volume reactions containing 3–4 μl of sodium bisulfite-
treated DNA, 0.2 μM primers, and master mix contain-
ing Taq DNA polymerase (Sigma-Aldrich, St. Louis,
MO). Primer sequences can be found in Additional file
4: Table S2. PCR amplicons were processed for pyrose-
quencing analysis according to the manufacturer’s stand-
ard protocol using a PyroMark Q96 MD system
(QIAGEN, Germantown, MD) with Pyro Q-CpG 1.0.9
software (QIAGEN) for CpG methylation quantification.
Only data passing internal quality checks for sodium
bisulfite conversion efficiency, signal-to-noise ratio, and
the observed versus expected match of the predicted
pyrogram peak profile using reference peaks were incor-
porated in subsequent analyses. Data generated derive
from one technical replicate.
Blood analysis in PPD cohort
Participant blood was collected at each visit in four 10-
ml EDTA tubes. Blood samples were non-fasting, and
collection times were arranged at the convenience of the
participant. All occurred during the working day (9:00
am to 5:00 pm). Cytokine levels have a recognized circa-
dian rhythm but are lowest during the daytime; we were
unable to control further for time of day in our analyses
[60]. Samples were immediately centrifuged at 4 °C for
30 min. The plasma was then aliquoted in 2-mL micro-
centrifuge tubes, snap frozen on dry ice, and immedi-
ately stored in a −80 °C freezer. Cytokines were analyzed
using BD Cytometric Bead Array. Plasma samples from
patients were diluted 1:10 and incubated with capture
beads coated with antibodies specific for IL-6. The beads
were then incubated with a phycoerythrin-conjugated
detection reagent containing antibodies specific to each
capture bead. The capture bead + analyte + detection re-
agent complexes produced an individual fluorescent signal
for each cytokine and were acquired on a FACSCalibur
instrument. The data were analyzed using FCAP Array
software. The limit of detection for IL-6 was 1.6 pg/mL.
Proportions of our samples that fell below the limit of
detection were as follows: IL-6, 18.9 %. Samples that fell
below the limit of detection were coded “0.” All samples
were run in duplicate, and the coefficient of variation
between samples was <10 %. Analyses were repeated using
the lowest detectable dose for those below the limit of
detection, and results did not change.
Statistical analysis
All statistical tests were performed in R (https://www.r-
project.org/). Cross-reactive Illumina probes were re-
moved from data prior to further analysis [61]. Using an
Anderson-Darling test from the “nortest” package [62],
all distributions of data that rejected the null hypothesis
of normality were subsequently evaluated with non-
parametric tests. Variance between case and control
groups in each sample was assumed to be equal. All stat-
istical tests performed were two tailed, and a P < 0.05
was considered significant. All statistics presented are a
result of either a linear regression model or a Monte
Carlo method permutation test (1000 permutations).
Unless otherwise specified, ± denotes the standard de-
viation of the mean. Cell sub-fraction percentages were
quantified for CD8 T cells, CD4 T cells, B cells, NK
cells, monocytes, and granulocytes using an algorithm
designed by Houseman et al. for the quantification of
the cell types using DNA methylation proxies [63]. A
buccal cell epigenetic profile was derived by taking the
mean of N = 109 buccal-derived HM450 microarray
profiles from a data set in GEO accession GSE25892.
Incorporation of the buccal-derived profile at N = 500
HM450 loci into the Houseman algorithm generated
training set, and incorporation of a buccal covariate
was used to retrain the Houseman algorithm to quan-
tify buccal profiles.
Additional files
Additional file 1: Title: GenRED Offspring Blood Cortisol Associated Probes.
Description: Table containing all probes nominally associated with AUC
weekday cortisol in the GenRED Offspring blood cohort (N = 18) with
the corresponding regression coefficient (β) and p-value. (XLSX 860 kb)
Additional file 2: Title: GenRED Offspring Saliva Cortisol Associated Probes.
Description: Table containing all probes nominally associated with AUC
weekday cortisol in the GenRED Offspring saliva cohort (N = 20) with
the corresponding regression coefficient (β) and p-value. (XLSX 958 kb)
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Additional file 3: Title: Combined GenRED Offspring Blood & Saliva
Cortisol Associated Probes. Description: Table containing all probes
nominally associated with AUC weekday cortisol in the combined
GenRED Offspring blood and saliva cohorts (N = 38) with the
corresponding regression coefficient (β) and p-value. (XLSX 1086 kb)
Additional file 4: Supplementary Data. Description: Contains
supplementary results, figures, and tables. (DOCX 2399 kb)
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